Follow-The-Filings

Security · featured owners

OLMA Olema Pharmaceuticals Inc

Olema Pharmaceuticals Inc. COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.2%
  • $12M

Who owns this now

Largest portfolio weights among featured holders · max 0.2% (Stanley Druckenmiller - Duquesne Family Office) · not free-float ownership

  1. Stanley Druckenmiller 0.24%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Stanley Druckenmiller - Duquesne Family Office 2026 Q2 0.24% Hold 986,827 $12M history

1 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$96.66M -$129.47M -$162.45M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $266.51M $438.47M $515.45M
Total non-current assets * $10.43M $12.51M $17.98M
Total assets $276.94M $450.98M $533.43M
Total current liabilities $21.62M $41.76M $51.8M
Total non-current liabilities * $1.43M $0.257M $3.07M
Total equity $253.9M $408.96M $478.56M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$83.73M -$104.35M -$146.72M
Cash from investing -$4.85M -$93.53M -$155.76M
Cash from financing $133.42M $268.82M $211.3M
Net change in cash $44.84M $70.94M -$91.18M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders